BENJAMIN F. EDWARDS & COMPANY, INC. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
BENJAMIN F. EDWARDS & COMPANY, INC. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$614
-0.8%
6,031
-1.7%
0.02%0.0%
Q2 2023$619
+10.7%
6,137
+1.0%
0.02%
+4.3%
Q1 2023$559
+2.4%
6,079
+1.1%
0.02%
-8.0%
Q4 2022$546
-100.0%
6,013
-61.3%
0.02%
-57.6%
Q3 2022$1,181,000
-11.6%
15,532
-1.7%
0.06%
-9.2%
Q2 2022$1,336,000
-0.8%
15,808
+3.0%
0.06%
+8.3%
Q1 2022$1,347,000
+9.2%
15,353
+8.9%
0.06%
+9.1%
Q4 2021$1,234,000
+3.6%
14,104
-3.1%
0.06%
-8.3%
Q3 2021$1,191,000
-7.0%
14,562
+3.8%
0.06%
-7.7%
Q2 2021$1,280,000
+6.8%
14,033
+0.1%
0.06%
+1.6%
Q1 2021$1,198,000
-6.3%
14,021
+3.6%
0.06%
-15.8%
Q4 2020$1,278,000
-0.1%
13,532
-8.0%
0.08%
-11.6%
Q3 2020$1,279,000
+0.2%
14,708
+0.6%
0.09%
-7.5%
Q2 2020$1,277,000
+8.1%
14,625
+2.1%
0.09%
-7.9%
Q1 2020$1,181,000
+3.8%
14,325
+19.1%
0.10%
+26.2%
Q4 2019$1,138,000
+75.9%
12,023
+61.5%
0.08%
+56.9%
Q3 2019$647,000
+34.2%
7,444
+41.0%
0.05%
+27.5%
Q2 2019$482,000
-6.6%
5,280
-1.6%
0.04%
-14.9%
Q1 2019$516,000
+2.6%
5,364
-8.6%
0.05%
-9.6%
Q4 2018$503,000
+11.0%
5,867
+11.6%
0.05%
+20.9%
Q3 2018$453,000
+23.8%
5,259
+8.5%
0.04%
+19.4%
Q2 2018$366,000
-70.6%
4,848
-68.5%
0.04%
-71.4%
Q1 2018$1,243,000
-34.9%
15,373
-32.4%
0.13%
-36.7%
Q4 2017$1,909,000
+1.7%
22,734
+4.0%
0.20%
-11.9%
Q3 2017$1,877,000
-2.4%
21,866
-5.1%
0.23%
-10.0%
Q2 2017$1,924,000
+12.5%
23,049
+0.1%
0.25%
-0.4%
Q1 2017$1,710,000
+2.9%
23,024
+0.9%
0.25%
-7.4%
Q4 2016$1,662,000
+100.0%
22,812
+116.9%
0.27%
+85.0%
Q3 2016$831,000
-4.6%
10,518
-0.3%
0.15%
-13.5%
Q2 2016$871,000
+27.9%
10,552
+12.2%
0.17%
+20.6%
Q1 2016$681,000
-12.2%
9,408
+4.4%
0.14%
-15.6%
Q4 2015$776,000
-1.8%
9,014
+4.9%
0.17%
-3.5%
Q3 2015$790,000
+10.3%
8,595
+18.0%
0.17%
+21.0%
Q2 2015$716,000
+7.8%
7,281
+8.1%
0.14%
+2.9%
Q1 2015$664,000
+39.5%
6,734
+31.2%
0.14%
+26.4%
Q4 2014$476,000
-4.2%
5,134
-2.8%
0.11%
-11.3%
Q3 2014$497,000
+31.1%
5,283
+26.0%
0.12%
+29.2%
Q2 2014$379,000
+25.9%
4,192
+18.3%
0.10%
+15.7%
Q1 2014$301,000
+7.1%
3,545
+1.5%
0.08%
-12.6%
Q4 2013$281,000
+2.6%
3,492
-2.2%
0.10%
-5.9%
Q3 2013$274,000
+3.0%
3,569
-5.1%
0.10%
-5.6%
Q2 2013$266,0003,7620.11%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders